VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 69 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,875 | -32.3% | 500 | 0.0% | 0.00% | – |
Q2 2023 | $5,725 | +48.5% | 500 | 0.0% | 0.00% | – |
Q1 2023 | $3,855 | +26.4% | 500 | 0.0% | 0.00% | – |
Q4 2022 | $3,050 | +1.7% | 500 | 0.0% | 0.00% | – |
Q3 2022 | $3,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q2 2022 | $3,000 | -25.0% | 500 | 0.0% | 0.00% | – |
Q1 2022 | $4,000 | +300.0% | 500 | 0.0% | 0.00% | – |
Q4 2021 | $1,000 | -85.7% | 500 | -80.0% | 0.00% | – |
Q3 2021 | $7,000 | -30.0% | 2,500 | 0.0% | 0.00% | – |
Q2 2021 | $10,000 | -16.7% | 2,500 | 0.0% | 0.00% | – |
Q1 2021 | $12,000 | -25.0% | 2,500 | +8.7% | 0.00% | – |
Q4 2020 | $16,000 | -36.0% | 2,300 | 0.0% | 0.00% | -100.0% |
Q3 2020 | $25,000 | -13.8% | 2,300 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $29,000 | +38.1% | 2,300 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $21,000 | -34.4% | 2,300 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $32,000 | -20.0% | 2,300 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $40,000 | -36.5% | 2,300 | 0.0% | 0.00% | -50.0% |
Q2 2019 | $63,000 | – | 2,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
Birchview Capital, LP | 33,000 | $310,000 | 0.29% |